Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Silvio E. Inzucchi
ResearcherPublications, citations & collaboration network
Silvio E. Inzucchi is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 750 works, 83,903 citations, an h-index of 116 and an i10-index of 395.
750
Works
83,903
Citations
116
h-index
395
i10-index
How has Silvio E. Inzucchi's publication output changed over time?
ScholarIQpublication output · 2000–2022
Output grew200% over the shown period — from 1 works in 2000 to 3 in 2022.
1
1
1
1
1
2
1
1
3
200020092012201420152016201920202022
What are the most-cited papers on Silvio E. Inzucchi?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
New England Journal of Medicine. 201512,121 CitationsOPEN ACCESS
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
New England Journal of Medicine. 20197,005 CitationsOPEN ACCESS
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner, Silvio E. Inzucchi, John M. Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Bernard Zinman
New England Journal of Medicine. 20163,655 CitationsOPEN ACCESS
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews
Diabetes Care. 20123,220 CitationsOPEN ACCESS
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews
Diabetes Care. 20143,087 CitationsOPEN ACCESS
Related on ScholarIQ
Brigham and Women's Hospital
Institution
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Paper
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Paper
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Paper
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Paper
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Paper